Vijaya Diagnostic Centre Ltd has announced the acquisition of the diagnostic business of Arya Wellness Centre in Guwahati for Rs 46.20 crore. Executed via a slump sale, this strategic move marks the company’s entry into Assam to strengthen its North-East India footprint. The deal, which adds established pathology and radiology operations, is expected to close within 90 days, subject to regulatory approvals.
Vijaya Diagnostic Expands North-East Footprint with Rs 46.20 Crore Acquisition
Target Business: Diagnostic undertaking of Arya Wellness Centre. Consideration: Rs 46.20 crore cash payment.
Reader Takeaway: Expansion into Assam bolsters regional presence; watch for integration timeline and closing condition fulfillment.
What just happened
Vijaya Diagnostic Centre Ltd has received board approval to acquire the integrated diagnostic business of Arya Wellness Centre located in Guwahati, Assam. The transaction is structured as a slump sale, allowing the company to acquire the business as a going concern from NEMRIL HRPL JV. The deal is valued at Rs 46.20 crore in cash, subject to working capital adjustments.
Why this matters
This acquisition is a calculated step in Vijaya Diagnostic’s expansion strategy, specifically targeting the North-East India market. By taking over an established setup, the company avoids the time-intensive process of greenfield development in a new geography. The target business provides both pathology and radiology services, which align with Vijaya's core service offerings.
Financial Snapshot
The target business has demonstrated steady growth in recent years. Its turnover was Rs 22.99 crore in FY24, Rs 25.61 crore in FY25, and Rs 26.95 crore in FY26, highlighting a consistent revenue base that will now contribute to Vijaya Diagnostic’s consolidated financials upon integration.
What changes now
Upon completion of the deal, which is expected within 90 days, Vijaya Diagnostic will secure 100% operational control over the Guwahati units. The company has confirmed that this is an arm's length transaction and is not a related party deal, as no promoters or group entities have interests in the seller.
Risks to watch
Investors should track the fulfillment of conditions precedent as outlined in the Business Transfer Agreement. The deal remains subject to standard statutory and regulatory clearances. Any delays in securing these approvals or unexpected hurdles during the integration phase could impact the anticipated timeline.
What to track next
The primary focus for shareholders will be the official completion announcement and the subsequent operational integration of these new assets into Vijaya’s wider network.